MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹10,233 Cr | ₹5.27 Cr | ₹-740 Cr | ₹605 Cr | ₹-7.81 Cr |
What is the latest Cash Flow from Financing Activities ratio of MANKIND PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹10,233 Cr |
| Mar2024 | ₹5.27 Cr |
| Mar2023 | ₹-740 Cr |
| Mar2022 | ₹605 Cr |
| Mar2021 | ₹-7.81 Cr |
How is Cash Flow from Financing Activities of MANKIND PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹10,233 Cr | 194,066.22 | |
| Mar2024 | ₹5.27 Cr | Positive | |
| Mar2023 | ₹-740 Cr | Negative | |
| Mar2022 | ₹605 Cr | Positive | |
| Mar2021 | ₹-7.81 Cr | - | |
Compare Cash Flow from Financing Activities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹92,050.3 Cr | -0.6% | -8.8% | -11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,764.0 Cr | 2% | 6.1% | 4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,489.0 Cr | 0.1% | -3.5% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,442.0 Cr | -0.3% | 3.8% | 15.5% | Stock Analytics | |
| CIPLA | ₹123,088.0 Cr | 1.1% | -1.1% | 2.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,162.0 Cr | 2% | 4.8% | 4.8% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.6% |
-8.8% |
-11.9% |
| SENSEX | 0.9% |
0.8% |
7.1% |
You may also like the below Video Courses